mdj...my thoughts and logic on history repeating itself....Pfizer, $6.4 Billion for Arena Pharma...small cannabinoid pharma pipeline
Pfizer, +$50 Billion for Seagen....targeted payload delivery
LABS....pharmaceutical supplier of cannabinoid compounds to the likes of Arena and Seagen
History repeating itself? Astrazeneca taking out FUSN and their targeted payload delivery tech
How will history repeat itself for LABS????
Pfizer has a division that supplies active pharma molecules to other pharma companies but they do NOT have active pharma molecules based on cannabinoids....it is the missing piece of the puzzle for Pfizer and Bourla's comment of 1 out of 3 will get cancer in conjunction with the FDA stating clearly that cannabinoids have applications to treat cancer.